One of the most exciting developments in precision and regenerative medicine today is peptide therapy. But while peptides have become popular in sports medicine, chronic disease management, and more, there is also significant confusion about them. How can you know what peptides are legitimate, and where should you buy them? In today’s article, I discuss existing and emerging peptides, problems within the current peptide marketplace, and how we can solve them.
What Is a Peptide?
Peptides are short chains of amino acids, the building blocks of proteins. They act as biological signaling molecules that help cells communicate and regulate important functions throughout the body, such as tissue repair, immune response, hormonal balance, metabolism, brain function, sleep, inflammation control, and wound healing. Some of the peptides naturally produced by the body include: insulin, glucagon, oxytocin, calcitonin, endorphins, and collagen-derived peptides.
Because peptides are natural signaling molecules already found in the body, they have attracted attention for their potential to support health and recovery. What many people don’t realize is that peptides are already used in some of today’s most widely-prescribed medications – from Ozempic and Wegovy to insulin and Calcitonin.
Emerging Peptides and Current Research
Beyond commonly prescribed peptide medications, numerous peptides are currently being researched for regenerative and anti-inflammatory applications. Some the most significant peptides currently gaining notice include:
- BPC 157 – derived from a naturally occurring gastric protein. Supports tendon healing, ligaments, muscle recovery, gut health, and inflammatory conditions.
- GHK Cu (Copper Peptide) – a naturally occurring human peptide that declines with age. Helps tissue repair, skin rejuvenation, hair growth, collagen production, anti-inflammatory activity, and wound healing.
- TB 500 – a synthetic version of a naturally occurring peptide fragment. Supports injury recovery, muscle repair, tendon healing, and inflammation modulation.
- MOTS C – a mitochondrial-derived peptide. Supports metabolic health, exercise performance, healthy aging, and cellular energy production.
- Semax – supports cognition, focus and concentration, neurological health, and neuroprotection.
- Epitalon – has shown potential in supporting healthy aging, sleep regulation, cellular repair, and longevity applications.
- Thymosin Alpha 1 – supports immune system modulation and has been studied for chronic infection defense, immune resilience, and possible applications in oncology.
The Problem with the Current Peptide Marketplace
For years, restrictions on compounding certain peptides have pushed patients towards products of dubious quality and questionable sources – whether that’s overseas suppliers, internet vendors, or research chemical companies. This raises significant safety concerns.
Many peptides sold through unregulated channels arrive as lyophilized powders in vials that require reconstitution with sterile water. Once reconstituted, degradation begins immediately. Depending on the peptide, storage conditions, and manufacturing quality, potency declines over time. Many patients continue to use the same vial for days or weeks after reconstitution, often unaware that the product may no longer have the same potency or stability. This becomes especially problematic when patients repeatedly access the same vial without knowing whether the product remains sterile, stable, or effective.
Why Pharmacy Compounding Matters
Compounding pharmacies provide safeguards that are absent from the unregulated market products. Licensed compounding pharmacies can help verify the safety, quality, and effectiveness of products through sterility testing, potency verification, stability studies, beyond-use dating, controlled sourcing, regulatory oversight, physician oversight, and quality assurance programs.
This is fundamentally different from purchasing unknown powders from overseas manufacturers, which raises concerns of contamination, degradation, ingredient authenticity, and dosage accuracy.
A Potential Alternative to High-Cost Immune Suppression
One of the most exciting areas of peptide medicine is its potential role in supporting patients with chronic inflammatory and autoimmune conditions.
Many conventional specialty medications used to treat autoimmune diseases can cost tens of thousands of dollars annually and often work by suppressing important aspects of the immune system, which can cause other health problems. In some cases, patients who develop bacterial infections may not mount a normal immune response, potentially increasing the risk of severe infections, septicemia, and septic shock.
Throughout my career, I have personally worked with patients who have successfully utilized root cause treatments and peptide-based therapies as part of a comprehensive treatment strategy for inflammatory conditions. I have also seen America’s HealthShare members work with functional and integrative medicine physicians to significantly improve their symptoms, quality of life, and overall health while reducing healthcare costs.
At America’s HealthShare, we are excited about the possibility of supporting access to therapies such as BPC 157, when legally permitted, through proper providers and high-quality compounding pharmacies. Options like BPC 157 may offer members additional pathways to improved health while reducing reliance on expensive therapies.
Looking Forward: The Future of Peptides
So what does the future look like for peptide therapies in the U.S.? Thanks to Health and Human Services Secretary Robert F. Kennedy Jr., safe access to peptide therapies has become a focus point in policy development.
The FDA has scheduled meetings in July 2026 to evaluate whether several peptides, including BPC 157, TB 500, MOTS C, Semax, Epitalon, and others may be eligible for pharmacy compounding. This presents an important opportunity to move patients away from an unregulated marketplace and toward physician-supervised care supported by licensed compounding pharmacies.
At America’s HealthShare, we support efforts that expand access to safe, innovative, and affordable healthcare options. We believe patients should be able to work with qualified healthcare providers and reputable pharmacies rather than being forced to rely on products from unknown overseas sources. Expanding access to pharmacy-compounded peptides represents a common-sense step toward improving patient safety, improving outcomes, and advancing personalized medicine.
In Health,
Dr. John Oertle
Chief Medical Officer